Kevin Kotler
Investor
Kevin Kotler has over 28 years of experience as an investor and analyst following the healthcare industry. He was the Founder and Portfolio Manager of Broadfin Capital, LLC, which managed over $1 billion in capital. He currently serves on the board of BioDelivery Sciences and has previously served on the boards of Avadel Pharmaceuticals and Memorial Sloan Kettering's Technology Development Fund. He graduated from the University of Pennsylvania in 1993 with a degree in Economics.
